View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Neurocrine Biosciences Inc

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer

2009 APR 13 ... also supporting financing and business development activities. Prior to that, he was at Neurocrine Biosciences where he led several clinical development programs. Through his combined ... BrainCells Inc. (BCI), a company leading the scientific research of neurogenesis using its proprietary ...

Subject: Pharmaceuticals

Price: $3.00

Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

2009 AUG 10 ... Endometriosis, Estradiol, Gonadotropin, Gynecology, Hormones, Menstruation, Neurocrine Biosciences Inc., Peptide, Pharmaceuticals, Proteins, Proteomics, Therapy, Treatment,...

Subject: Endometriosis

Price: $3.00

Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain

2009 JUN 1 ... Research, Drugs, Endometriosis, Gonadotropin, Hormones, Medroxyprogesterone Acetate, Neurocrine Biosciences Inc., Peptide, Pharmaceuticals, Proteins, Proteomics, Provera, Therapy, Treatment,...

Subject: Endometriosis

Price: $3.00

Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

2009 APR 6 ... Company, Clinical Trial Research, Drugs, Endometriosis, FDA, Gonadotropin, Hormones, Neurocrine Biosciences Inc., Peptide, Pharmaceuticals, Proteins, Proteomics, Therapy, Treatment, U.S. Food and Drug ...

Subject: Endometriosis

Price: $3.00

Neurocrine Announces Work Force Restructuring

2009 MAY 18 ... Inc., Anxiety Disorder, Therapy, Treatment, Drug Discovery, Drug Development, Neurocrine Biosciences Inc., Biotechnology Business, Biotechnology Company This article was prepared ...

Subject: Neurocrine Biosciences, Inc.

Price: $3.00

Neurocrine Biosciences Amends Corporate Headquarters Lease

2009 OCT 12 ... Keywords: Anxiety Disorder, Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This article ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences Presents Elagolix Data

2009 JUN 29 ... Drugs, Endocrine, Endometriosis, Estradiol, Hot Flashes, Medroxyprogesterone Acetate, Neurocrine Biosciences Inc., Pharmaceuticals, Pharmacokinetics, Pre-Trials Research, Provera, Therapies, Therapy, ...

Subject: Pharmacokinetics

Price: $3.00

Neurocrine Biosciences Reports First Quarter 2009 Results

2009 MAY 18 ... Keywords: Biotechnology Business, Biotechnology Company, GlaxoSmithKline, Neurocrine Biosciences Inc., Pharmaceutical Business, Pharmaceutical Company,...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results

2009 FEB 16 ... Company, Dainippon Pharmaceutical Co. Ltd., Marketing and Licensing Agreements, Neurocrine Biosciences Inc., Pharmaceutical Business, Pharmaceutical Company, Sumitomo Pharmaceuticals Company ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences Reports Second Quarter 2009 Results

2009 AUG 10 ... Dainippon Pharmaceutical Co. Ltd., GlaxoSmithKline, Marketing and Licensing Agreements, Neurocrine Biosciences Inc., Pharmaceutical Business, Pharmaceutical Company, Sumitomo Pharmaceuticals Company ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences Reports Third Quarter 2009 Results

2009 NOV 9 ... Dainippon Pharmaceutical Co. Ltd., GlaxoSmithKline, Marketing and Licensing Agreements, Neurocrine Biosciences Inc., Pharmaceutical Business, Pharmaceutical Company, Sumitomo Pharmaceuticals Company ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences Secures Committed Equity Financing Facility

2009 SEP 28 ... Keywords: Anxiety Disorder, Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This article ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference

2009 SEP 14 ... for two weeks. Keywords: Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This article ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference

2009 SEP 28 ... for two weeks. Keywords: Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This article ...

Subject: Biotechnology Business

Price: $3.00

Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors

2009 JUL 20 ... with its commercialization and partnering activities. Gary has served as a Director of Neurocrine Biosciences, Inc. since February 1993 and held various executive positions with ...

Subject: Biotech Business

Price: $3.00

Premier Research Strengthens their Medical Affairs and Strategic Consulting Group with New Appointments

2009 SEP 21 ... Clinical Development at Allergan, Inc. Prior to that, Dr. Skinner has held positions at Neurocrine Biosciences and Eli Lilly & Co. He is a board certified in internal medicine and ...

Subject: Oncology

Price: $3.00

Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry

2009 JUL 13 ... Clinical Trial Research, Therapy, Treatment, Drug Discovery, Drug Development, Hormones, Neurocrine Biosciences Inc., Biotechnology Business, Biotechnology Company, Small Molecule Inhibitor, Gonadotropin, ...

Subject: Sundia MediTech Company

Price: $3.00

Neurocrine Biosciences Reports Third Quarter 2008 Results

2008 NOV 10 ... Dainippon Pharmaceutical Co. Ltd., GlaxoSmithKline, Marketing and Licensing Agreements, Neurocrine Biosciences Inc., Pharmaceutical Business, Pharmaceutical Company, Sumitomo Pharmaceuticals Company ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference

2008 DEC 8 ... for two weeks. Keywords: Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This ...

Subject: Biotechnology Business

Price: $3.00

Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference

2008 NOV 10 ... for two weeks. Keywords: Biotechnology Business, Biotechnology Company, Neurocrine Biosciences Inc., Neurocrine Biosciences Inc. This ...

Subject: Biotechnology Business

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx